112
Views
3
CrossRef citations to date
0
Altmetric
Review

Toll-like receptor cascade and gene polymorphism in host–pathogen interaction in Lyme disease

, , , &
Pages 91-102 | Published online: 31 May 2016

References

  • TillyKRosaPAStewartPEBiology of infection with Borrelia burgdorferiInfect Dis Clin North Am200822221723418452798
  • BerendeAOostingMKullbergBJNeteaMGJoostenLAActivation of innate host defense mechanisms by BorreliaEur Cytokine Netw201021171820146985
  • No authors listedLyme disease in Canada: Q and A for paediatriciansPaediatr Child Health200914210310819436561
  • MeadPSEpidemiology of Lyme diseaseInfect Dis Clin North Am201529218721025999219
  • HoKMelansonMDesaiJABell palsy in Lyme disease-endemic regions of Canada: a cautionary case of occult bilateral peripheral facial nerve palsy due to Lyme diseaseCJEM201214532132422967702
  • OgdenNHBouchardCKurtenbachKActive and passive surveillance and phylogenetic analysis of Borrelia burgdorferi elucidate the process of Lyme disease risk emergence in CanadaEnviron Health Perspect2010118790991420421192
  • KoffiJKLeightonPAPelcatYPassive surveillance for I. scapularis ticks: enhanced analysis for early detection of emerging Lyme disease riskJ Med Entomol201249240040922493860
  • OgdenNHKoffiJKPelcatYLindsayREnvironmental risk from Lyme disease in central and eastern Canada: a summary of recent surveillance informationCan Commun Dis Rep20144057482
  • HatchetteTIanDJohnstonLLyme disease: clinical diagnosis and treatmentCCDR20144011194208
  • HatchetteTFJohnstonBLSchleihaufEEpidemiology of Lyme disease, Nova Scotia, Canada, 2002–2013Emerg Infect Dis201521101751175826401788
  • AucottJMorrisonCMunozBRowePCSchwarzwalderAWestSKDiagnostic challenges of early Lyme disease: lessons from a community case seriesBMC Infect Dis200997919486523
  • SteereACCoburnJGlicksteinLThe emergence of Lyme diseaseJ Clin Invest200411381093110115085185
  • ShapiroEDAuwaerterPBorrelia burgdorferi (Lyme disease)LongSSPickeringLKProberCGPrinciples and Practice of Pediatric Infectious DiseasesNew YorkChurchill Livingstone1997
  • OgdenNHLindsayLRMorshedMSockettPNArtsobHThe emergence of Lyme disease in CanadaCMAJ2009180121221122419506281
  • WormserGPDattwylerRJShapiroEDThe clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of AmericaClin Infect Dis20064391089113417029130
  • TakedaKAkiraSTLR signaling pathwaysSemin Immunol20041613914751757
  • BeutlerBInnate immunity: an overviewMol Immunol2004401284585914698223
  • ChoeJKelkerMSWilsonIACrystal structure of human Toll-like receptor 3 (TLR3) ectodomainScience2005309573458158515961631
  • AlbigerBDahlbergSHenriques-NormarkBNormarkSRole of the innate immune system in host defence against bacterial infections: focus on the Toll-like receptorsJ Intern Med2007261651152817547708
  • KumarSIngleHPrasadDVKumarHRecognition of bacterial infection by innate immune sensorsCrit Rev Microbiol201339322924622866947
  • WootenRMModurVRMcIntyreTMWeisJJBorrelia burgdorferi outer membrane protein A induces nuclear translocation of nuclear factor-κB and inflammatory activation in human endothelial cellsJ Immunol199615710458445908906837
  • MaYWeisJJBorrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory propertiesInfect Immun1993619384338538359905
  • MaYSeilerKPTaiKFYangLWoodsMWeisJJOuter surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathwayInfect Immun1994629366336717520417
  • MorrisonTBWeisJHWeisJJBorrelia burgdorferi outer surface protein A (OspA) activates and primes human neutrophilsJ Immunol199715810483848459144499
  • SchnareMRöllinghoffMQureshiSToll-like receptors: sentinels of host defence against bacterial infectionInt Arch Allergy Immunol20061391758516319494
  • BernardinoALMyersTAAlvarezXHasegawaAPhilippMTToll-like receptors: insights into their possible role in the pathogenesis of Lyme neuroborreliosisInfect Immun200876104385439518694963
  • PetzkeMMBrooksAKrupnaMAMordueDSchwartzIRecognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cellsJ Immunol200918385279529219794067
  • RadolfJDCaimanoMJStevensonBHuLTOf ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetesNat Rev Microbiol2012102879922230951
  • BatsfordSDunnJMihatschMOuter surface lipoproteins of Borrelia burgdorferi vary in their ability to induce experimental joint injuryArthritis Rheum20045072360236915248237
  • DuChateauBKMunsonELEnglandDMMacrophages interact with enriched populations of distinct T lymphocyte subsets for the induction of severe destructive Lyme arthritisJ Leukoc Biol199965216217010088598
  • BriglMBryLKentSCGumperzJEBrennerMBMechanism of CD1d-restricted natural killer T cell activation during microbial infectionNat Immunol20034121230123714578883
  • LinYTVermaAHodgkinsonCPToll-like receptors and human disease: lessons from single nucleotide polymorphismsCurr Genomics201213863364523730203
  • CervantesJLHawleyKLBenjaminSJWeinermanBLuuSMSalazarJCPhagosomal TLR signaling upon Borrelia burgdorferi infectionFront Cell Infect Microbiol201445524904837
  • BenhniaMRWroblewskiDAkhtarMNSignaling through CD14 attenuates the inflammatory response to Borrelia burgdorferi, the agent of Lyme diseaseJ Immunol200517431539154815661914
  • ParveenNCornellKABonoJLChamberlandCRosaPLeongJMBgp, a secreted glycosaminoglycan-binding protein of Borrelia burgdorferi strain N40, displays nucleosidase activity and is not essential for infection of immunodeficient miceInfect Immun20067453016302016622242
  • KraiczyPSkerkaCKirschfinkMBradeVZipfelPFImmune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and factor HEur J Immunol20013161674168411385611
  • XuHHeMHeJJYangXFRole of the surface lipoprotein BBA07 in the enzootic cycle of Borrelia burgdorferiInfect Immun20107872910291820421380
  • RevelATBlevinsJSAlmazánCBptA (bbe16) is essential for the persistence of the Lyme disease spirochete, Borrelia burgdorferi, in its natural tick vectorProc Natl Acad Sci U S A2005102196972697715860579
  • LiXPalURamamoorthiNThe Lyme disease agent Borrelia burgdorferi requires BB0690, a Dps homologue, to persist within ticksMol Microbiol200763369471017181780
  • ZhangLZhangYAdusumilliSMolecular interactions that enable movement of the Lyme disease agent from the tick gut into the hemolymphPLoS Pathog201176e100207921695244
  • KumarMKaurSKariuTBorrelia burgdorferi BBA52 is a potential target for transmission blocking Lyme disease vaccineVaccine201129489012901921945261
  • TokarzRAndertonJMKatonaLIBenachJLCombined effects of blood and temperature shift on Borrelia burgdorferi gene expression as determined by whole genome DNA arrayInfect Immun20047295419543215322040
  • MarchalCMLuftBJYangXSibiliaJJaulhacBBoulangerNMDefensin is suppressed by tick salivary gland extract during the in vitro interaction of resident skin cells with Borrelia burgdorferiJ Invest Dermatol2009129102515251719340008
  • PalUYangXChenMOspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glandsJ Clin Invest2004113222023014722614
  • LagalVPortnoïDFaureGPosticDBarantonGBorrelia burgdorferi sensu stricto invasiveness is correlated with OspC-plasminogen affinityMicrobes Infect20068364565216513394
  • FlodenAMWattJABrissetteCABorrelia burgdorferi enolase is a surface-exposed plasminogen binding proteinPLoS One2011611e2750222087329
  • HallströmTHauptKKraiczyPComplement regulator-acquiring surface protein 1 of Borrelia burgdorferi binds to human bone morphogenic protein 2, several extracellular matrix proteins, and plasminogenJ Infect Dis2010202349049820565259
  • ColemanJLBenachJLThe urokinase receptor can be induced by Borrelia burgdorferi through receptors of the innate immune systemInfect Immun200371105556556414500474
  • ColemanJLRoemerEJBenachJLPlasmin-coated Borrelia burgdorferi degrades soluble and insoluble components of the mammalian extracellular matrixInfect Immun19996783929393610417158
  • HsiehYFLiuHWHsuTCSerum reactivity against Borrelia burgdorferi OspA in patients with rheumatoid arthritisClin Vaccine Immunol200714111437144117881508
  • ScheckelhoffMRTelfordSRWesleyMHuLTBorrelia burgdorferi intercepts host hormonal signals to regulate expression of outer surface protein AProc Natl Acad Sci U S A2007104177247725217438273
  • GrossDMHuberBTCellular and molecular aspects of Lyme arthritisCell Mol Life Sci200057111562156911092451
  • GhoshSHuberBTClonal diversification in OspA-specific antibodies from peripheral circulation of a chronic Lyme arthritis patientJ Immunol Methods20073211–212113417307198
  • SaloJLoimarantaVLahdennePViljanenMKHytönenJDecorin binding by DbpA and B of Borrelia garinii, Borrelia afzelii, and Borrelia burgdorferi sensu strictoJ Infect Dis20112041657321628660
  • LaFranceMEPierceJVAntonaraSCoburnJThe Borrelia burgdorferi integrin ligand P66 affects gene expression by human cells in cultureInfect Immun20117983249326121576330
  • FikrigEFengWBartholdSWTelfordSRFlavellRAArthropod-and host-specific Borrelia burgdorferi bbk32 expression and the inhibition of spirochete transmissionJ Immunol2000164105344535110799897
  • BrissetteCABykowskiTCooleyAEBowmanAStevensonBBorrelia burgdorferi RevA antigen binds host fibronectinInfect Immun20097772802281219398540
  • BrissetteCAVermaABowmanACooleyAEStevensonBThe Borrelia burgdorferi outer-surface protein ErpX binds mammalian lamininMicrobiology2009155386387219246757
  • VermaABrissetteCABowmanAStevensonBBorrelia burgdorferi BmpA is a laminin-binding proteinInfect Immun200977114940494619703983
  • PulzovaLBhideMOuter surface proteins of Borrelia: peerless immune evasion toolsCurr Protein Pept Sci2014151758824555888
  • YangXIzadiHColemanASBorrelia burgdorferi lipoprotein BmpA activates pro-inflammatory responses in human synovial cells through a protein moietyMicrobes Infect20081012–131300130818725314
  • EkdahlKNHenningssonAJSandholmKForsbergPErnerudhJEkerfeltCImmunity in borreliosis with special emphasis on the role of complementAdv Exp Med Biol200759819821317892213
  • McDowellJVWolfgangJTranEMettsMSHamiltonDMarconiRTComprehensive analysis of the factor H binding capabilities of Borrelia species associated with Lyme disease: delineation of two distinct classes of factor H binding proteinsInfect Immun20037163597360212761145
  • KraiczyPHellwageJSkerkaCComplement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteinsJ Biol Chem200427942421242914607842
  • HammerschmidtCKoenigsASiegelCVersatile roles of CspA orthologs in complement inactivation of serum-resistant Lyme disease spirochetesInfect Immun201482138039224191298
  • LoveACSchwartzIPetzkeMMBorrelia burgdorferi RNA induces type I and III interferons via Toll-like receptor 7 and contributes to production of NF-κB-dependent cytokinesInfect Immun20148262405241624664510
  • CervantesJLDunham-EmsSMLa VakeCJPhagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-βProc Natl Acad Sci U S A201110893683368821321205
  • SinghSKGirschickHJToll-like receptors in Borrelia burgdorferi-induced inflammationClin Microbiol Infect200612870571716842565
  • AlexopoulouLThomasVSchnareMHyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1-and TLR2-deficient miceNat Med20028887888412091878
  • WootenRMMorrisonTBWeisJHWrightSDThieringerRWeisJJThe role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferiJ Immunol199816011548554929605151
  • BlancoDRRadolfJDLovettMAMillerJNThe antigenic interrelationship between the endoflagella of Treponema phagedenis biotype Reiter and Treponema pallidum Nichols strain. I. Treponemicidal activity of cross-reactive endoflagellar antibodies against T. pallidumJ Immunol19861379297329793531343
  • StrleKShinJJGlicksteinLJSteereACAssociation of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritisArthritis Rheum20126451497150722246581
  • TeixeiraMMAlmeidaICGazzinelliRTIntroduction: innate recognition of bacteria and protozoan parasitesMicrobes Infect20024988388612106780
  • BadawiAKlipAHaddadPType 2 diabetes mellitus and inflammation: prospects for biomarkers of risk and nutritional interventionDiabetes Metab Syndr Obes2010317318621437087
  • MedzhitovRRecognition of microorganisms and activation of the immune responseNature2007449716481982617943118
  • FrazãoJBErrantePRCondino-NetoAToll-like receptors’ pathway disturbances are associated with increased susceptibility to infections in humansArch Immunol Ther Exp (Warsz)201361642744324057516
  • SalazarJCDuhnam-EmsSLa VakeCActivation of human monocytes by live Borrelia burgdorferi generates TLR2-dependent and-independent responses which include induction of IFN-βPLoS Pathog200955e100044419461888
  • TakeuchiOSatoSHoriuchiTCutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteinsJ Immunol20021691101412077222
  • BulutYFaureEThomasLEquilsOArditiMCooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signalingJ Immunol2001167298799411441107
  • JablonskaEMarcinczykMTLR2 expression in relation to IL-6 and IL-1 β and their natural regulators production by PMN and PBMC in patients with Lyme diseaseMediators Inflamm2006200613207116864901
  • WootenRMMaYYoderRAToll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferiJ Immunol2002168134835511751980
  • ShinOSIsbergRRAkiraSUematsuSBeheraAKHuLTDistinct roles for MyD88 and Toll-like receptors 2, 5, and 9 in phagocytosis of Borrelia burgdorferi and cytokine inductionInfect Immun20087662341235118378636
  • BolzDDSundsbakRSMaYMyD88 plays a unique role in host defense but not arthritis development in Lyme diseaseJ Immunol200417332003201015265935
  • LiuNMontgomeryRRBartholdSWBockenstedtLKMyeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected miceInfect Immun20047263195320315155621
  • WangGMaYBuyukAMcClainSWeisJJSchwartzIImpaired host defense to infection and Toll-like receptor 2-independent killing of Borrelia burgdorferi clinical isolates in TLR2-deficient C3H/HeJ miceFEMS Microbiol Lett2004231221922514987768
  • SchröderNWDiterichIZinkeAHeterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme diseaseJ Immunol200517542534254016081826
  • Petnicki-OcwiejaTChungEAcostaDITRIF mediates Toll-like receptor 2-dependent inflammatory responses to Borrelia burgdorferiInfect Immun201381240241023166161
  • FarhatKRiekenbergSHeineHHeterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signalingJ Leukoc Biol200883369270118056480
  • SatoshiUShizuoAToll-like receptors and type I interferonsJ Biol Chem2009282211531915324
  • CervantesJLLa VakeCJWeinermanBHuman TLR8 is activated upon recognition of Borrelia burgdorferi RNA in the phagosome of human monocytesJ Leukoc Biol20139461231124123906644
  • GautamJKComeauLDKruegerJKSmithMFStructural and functional evidence for the role of the TLR2 DD loop in TLR1/TLR2 heterodimerization and signalingJ Biol Chem200628140301323014216893894
  • HawnTRMischEDunstanSJA common human TLR1 polymorphism regulates the innate immune response to lipopeptidesEur J Immunol20073782280228917595679
  • KangTJChaeGTDetection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patientsFEMS Immunol Med Microbiol2001311535811476982
  • Ben-AliMBarboucheMRBousninaSChabbouADellagiKToll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patientsClin Diagn Lab Immunol200411362562615138193
  • DalgicNTekinDKayaaltiZArg753Gln polymorphism of the human Toll-like receptor 2 gene from infection to disease in pediatric tuberculosisHum Immunol201172544044521320563
  • WuHYangLArg753Gln polymorphisms in Toll-like receptor 2 gene are associated with tuberculosis risk: a meta-analysisMed Sci Monit2015212196220226220088
  • OostingMTer HofstedeHSturmPTLR1/TLR2 heterodimers play an important role in the recognition of Borrelia spirochetesPLoS One2011610e2599821998742
  • SellatiTJSahayBWormserGPThe toll of a TLR1 polymorphism in Lyme disease: a tale of mice and menArthritis Rheum20126451311131522246662
  • StrleKJonesKLDrouinEELiXSteereACBorrelia burgdorferi RST1 (OspC type A) genotype is associated with greater inflammation and more severe Lyme diseaseAm J Pathol201117862726273921641395
  • JonesKLMcHughGAGlicksteinLJSteereACAnalysis of Borrelia burgdorferi genotypes in patients with Lyme arthritis: high frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritisArthritis Rheum20096072174218219565522
  • SteereACDurayPHButcherECSpirochetal antigens and lymphoid cell surface markers in Lyme synovitisArthritis Rheum19883144874953258751
  • KwonJMGoateAMThe candidate gene approachAlcohol Res Health200024316416811199286
  • BushWSMooreJHChapter 11: Genome-wide association studiesPLoS Comput Biol2012812e100282223300413
  • BudulacSEBoezenHMHiemstraPSToll-like receptor (TLR2 and TLR4) polymorphisms and chronic obstructive pulmonary diseasePLoS One201278e4312422952638